Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-28 Purchase(A) | 2023-12-21 4:01 pm | Organicell Regenerative Medicine Inc. | OCEL | Leider Harry L. Chief Executive Officer | 1,049,450 | $0.00995 | $10,440 | 1,049,450 (Indirect) | View |
| 2023-12-19 Sale | 2023-12-20 4:05 pm | Organicell Regenerative Medicine Inc. | OCEL | Leider Harry L. Chief Executive Officer | 5,248 | $1.315 | $6,901 | 0 (Indirect) | View |
| 2023-06-28 Purchase | 2023-06-30 4:05 pm | Organicell Regenerative Medicine Inc. | OCEL | Leider Harry L. Chief Executive Officer | 1,049,450 | $0.0566 | $59,396 | 1,049,450 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-06-09 4:35 pm | 2023-09-06 2028-06-06 | Organicell Regenerative Medicine Inc. | OCEL | Leider Harry L. CEO and Director | 0 | $0 | 57,000,000 (Direct) | View |
| 2022-05-06 Option Award | 2022-05-09 4:17 pm | N/A 2032-03-03 | GELESIS HOLDINGS INC. | GLS | Leider Harry L. Chief Medical Officer | 314,090 | $0 | 583,750 (Direct) | View |
Ownership | 2022-01-24 4:40 pm | N/A 2027-01-13 | GELESIS HOLDINGS INC. | GLS | Leider Harry L. Chief Medical Officer | 0 | $0 | 963,167 (Direct) | View |